{"id":15105,"date":"2021-08-17T15:20:08","date_gmt":"2021-08-17T14:20:08","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=15105"},"modified":"2021-08-23T12:41:22","modified_gmt":"2021-08-23T11:41:22","slug":"webinar-a-foundation-briefing-on-industry-amr-surveillance-data-for-action-30-september-2021-300-600-pm","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/webinar-a-foundation-briefing-on-industry-amr-surveillance-data-for-action-30-september-2021-300-600-pm\/","title":{"rendered":"Webinar: A Foundation Briefing on Industry AMR Surveillance, Data for Action, 30 September 2021, 3:00-6:00 PM"},"content":{"rendered":"\n

Join Vivli for a Foundation Briefing on Industry AMR Surveillance: Data for Action<\/p>\n\n\n\n

Featuring Remarks from:
Dame Sally Davies
UK Special Envoy on Antimicrobial Resistance, UK Government; Master of Trinity College, Cambridge<\/p>\n\n\n\n

Dr. Marc Mendelson
Professor of Infectious Diseases and Head of the Division of Infectious Diseases & HIV Medicine at Groote Schuur Hospital, University of Cape Town<\/p>\n\n\n\n

Goals of this meeting are:
\u2022 To educate attendees about AMR and the benefits of sharing surveillance data
\u2022 To gain financial support from foundations for future sustainability of the platform
\u2022 To encourage potential data contributors to share their surveillance data on the register
\u2022 Hear from high profile speakers from government agencies and foundations invited by Wellcome and Vivli<\/p>\n\n\n\n

The event will take place September 30, 2021 from 09:00-12:00 ET, 14:00-17:00 BST, 22:00-01:00 JST<\/p>\n\n\n\n

Registration to the event here<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"

Join Vivli for a Foundation Briefing on Industry AMR Surveillance: Data for Action Featuring Remarks from:Dame Sally DaviesUK Special Envoy on Antimicrobial Resistance, UK Government; Master of Trinity College, Cambridge Dr. Marc MendelsonProfessor of Infectious Diseases and Head of the Division of Infectious Diseases & HIV Medicine at Groote Schuur Hospital, University of Cape Town […]<\/p>\n","protected":false},"author":139,"featured_media":15111,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[35],"tags":[],"acf":[],"yoast_head":"\nWebinar: A Foundation Briefing on Industry AMR Surveillance, Data for Action, 30 September 2021, 3:00-6:00 PM - Interface nationale ANTIBIOR\u00c9SISTANCE<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/webinar-a-foundation-briefing-on-industry-amr-surveillance-data-for-action-30-september-2021-300-600-pm\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Webinar: A Foundation Briefing on Industry AMR Surveillance, Data for Action, 30 September 2021, 3:00-6:00 PM - Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/webinar-a-foundation-briefing-on-industry-amr-surveillance-data-for-action-30-september-2021-300-600-pm\/\" \/>\n<meta property=\"og:site_name\" content=\"Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-17T14:20:08+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-08-23T11:41:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/08\/Online-webinar.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"481\" \/>\n\t<meta property=\"og:image:height\" content=\"221\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"\u00c9milie Noguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u00c9milie Noguez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/webinar-a-foundation-briefing-on-industry-amr-surveillance-data-for-action-30-september-2021-300-600-pm\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/webinar-a-foundation-briefing-on-industry-amr-surveillance-data-for-action-30-september-2021-300-600-pm\/\"},\"author\":{\"name\":\"\u00c9milie Noguez\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\"},\"headline\":\"Webinar: A Foundation Briefing on Industry AMR Surveillance, Data for Action, 30 September 2021, 3:00-6:00 PM\",\"datePublished\":\"2021-08-17T14:20:08+00:00\",\"dateModified\":\"2021-08-23T11:41:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/webinar-a-foundation-briefing-on-industry-amr-surveillance-data-for-action-30-september-2021-300-600-pm\/\"},\"wordCount\":145,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/webinar-a-foundation-briefing-on-industry-amr-surveillance-data-for-action-30-september-2021-300-600-pm\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/08\/Online-webinar.jpg\",\"articleSection\":[\"Ev\u00e8nements & Colloques\"],\"inLanguage\":\"fr-FR\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/webinar-a-foundation-briefing-on-industry-amr-surveillance-data-for-action-30-september-2021-300-600-pm\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/webinar-a-foundation-briefing-on-industry-amr-surveillance-data-for-action-30-september-2021-300-600-pm\/\",\"name\":\"Webinar: A Foundation Briefing on Industry AMR Surveillance, Data for Action, 30 September 2021, 3:00-6:00 PM - Interface nationale ANTIBIOR\u00c9SISTANCE\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/webinar-a-foundation-briefing-on-industry-amr-surveillance-data-for-action-30-september-2021-300-600-pm\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/webinar-a-foundation-briefing-on-industry-amr-surveillance-data-for-action-30-september-2021-300-600-pm\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/08\/Online-webinar.jpg\",\"datePublished\":\"2021-08-17T14:20:08+00:00\",\"dateModified\":\"2021-08-23T11:41:22+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/webinar-a-foundation-briefing-on-industry-amr-surveillance-data-for-action-30-september-2021-300-600-pm\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/webinar-a-foundation-briefing-on-industry-amr-surveillance-data-for-action-30-september-2021-300-600-pm\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/webinar-a-foundation-briefing-on-industry-amr-surveillance-data-for-action-30-september-2021-300-600-pm\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/08\/Online-webinar.jpg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/08\/Online-webinar.jpg\",\"width\":481,\"height\":221,\"caption\":\"Cr\u00e9dit : Pixabay\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/webinar-a-foundation-briefing-on-industry-amr-surveillance-data-for-action-30-september-2021-300-600-pm\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Infos pratiques & communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Ev\u00e8nements & Colloques\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Webinar: A Foundation Briefing on Industry AMR Surveillance, Data for Action, 30 September 2021, 3:00-6:00 PM\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"name\":\"Interface nationale ANTIBIOR\u00c9SISTANCE\",\"description\":\"PPR Antibior\u00e9sistance - Inserm\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\",\"name\":\"\u00c9milie Noguez\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Webinar: A Foundation Briefing on Industry AMR Surveillance, Data for Action, 30 September 2021, 3:00-6:00 PM - Interface nationale ANTIBIOR\u00c9SISTANCE","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/webinar-a-foundation-briefing-on-industry-amr-surveillance-data-for-action-30-september-2021-300-600-pm\/","og_locale":"fr_FR","og_type":"article","og_title":"Webinar: A Foundation Briefing on Industry AMR Surveillance, Data for Action, 30 September 2021, 3:00-6:00 PM - Interface nationale ANTIBIOR\u00c9SISTANCE","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/webinar-a-foundation-briefing-on-industry-amr-surveillance-data-for-action-30-september-2021-300-600-pm\/","og_site_name":"Interface nationale ANTIBIOR\u00c9SISTANCE","article_published_time":"2021-08-17T14:20:08+00:00","article_modified_time":"2021-08-23T11:41:22+00:00","og_image":[{"width":481,"height":221,"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/08\/Online-webinar.jpg","type":"image\/jpeg"}],"author":"\u00c9milie Noguez","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"\u00c9milie Noguez","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/webinar-a-foundation-briefing-on-industry-amr-surveillance-data-for-action-30-september-2021-300-600-pm\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/webinar-a-foundation-briefing-on-industry-amr-surveillance-data-for-action-30-september-2021-300-600-pm\/"},"author":{"name":"\u00c9milie Noguez","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3"},"headline":"Webinar: A Foundation Briefing on Industry AMR Surveillance, Data for Action, 30 September 2021, 3:00-6:00 PM","datePublished":"2021-08-17T14:20:08+00:00","dateModified":"2021-08-23T11:41:22+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/webinar-a-foundation-briefing-on-industry-amr-surveillance-data-for-action-30-september-2021-300-600-pm\/"},"wordCount":145,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/webinar-a-foundation-briefing-on-industry-amr-surveillance-data-for-action-30-september-2021-300-600-pm\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/08\/Online-webinar.jpg","articleSection":["Ev\u00e8nements & Colloques"],"inLanguage":"fr-FR"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/webinar-a-foundation-briefing-on-industry-amr-surveillance-data-for-action-30-september-2021-300-600-pm\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/webinar-a-foundation-briefing-on-industry-amr-surveillance-data-for-action-30-september-2021-300-600-pm\/","name":"Webinar: A Foundation Briefing on Industry AMR Surveillance, Data for Action, 30 September 2021, 3:00-6:00 PM - Interface nationale ANTIBIOR\u00c9SISTANCE","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/webinar-a-foundation-briefing-on-industry-amr-surveillance-data-for-action-30-september-2021-300-600-pm\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/webinar-a-foundation-briefing-on-industry-amr-surveillance-data-for-action-30-september-2021-300-600-pm\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/08\/Online-webinar.jpg","datePublished":"2021-08-17T14:20:08+00:00","dateModified":"2021-08-23T11:41:22+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/webinar-a-foundation-briefing-on-industry-amr-surveillance-data-for-action-30-september-2021-300-600-pm\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/webinar-a-foundation-briefing-on-industry-amr-surveillance-data-for-action-30-september-2021-300-600-pm\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/webinar-a-foundation-briefing-on-industry-amr-surveillance-data-for-action-30-september-2021-300-600-pm\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/08\/Online-webinar.jpg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/08\/Online-webinar.jpg","width":481,"height":221,"caption":"Cr\u00e9dit : Pixabay"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/webinar-a-foundation-briefing-on-industry-amr-surveillance-data-for-action-30-september-2021-300-600-pm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/"},{"@type":"ListItem","position":2,"name":"Infos pratiques & communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/"},{"@type":"ListItem","position":3,"name":"Ev\u00e8nements & Colloques","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/"},{"@type":"ListItem","position":4,"name":"Webinar: A Foundation Briefing on Industry AMR Surveillance, Data for Action, 30 September 2021, 3:00-6:00 PM"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","name":"Interface nationale ANTIBIOR\u00c9SISTANCE","description":"PPR Antibior\u00e9sistance - Inserm","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3","name":"\u00c9milie Noguez"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-24 12:15:49","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/15105"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/users\/139"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/comments?post=15105"}],"version-history":[{"count":5,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/15105\/revisions"}],"predecessor-version":[{"id":15119,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/15105\/revisions\/15119"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media\/15111"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media?parent=15105"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/categories?post=15105"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/tags?post=15105"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}